266 related articles for article (PubMed ID: 8608381)
1. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
Garcia C; Viehman G; Hitchcock M; Clark RE
Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans.
Garcia C; Clark RE; Buchanan M
Int J Dermatol; 1996 Dec; 35(12):867-71. PubMed ID: 8970843
[TBL] [Abstract][Full Text] [Related]
3. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.
Elgart GW; Hanly A; Busso M; Spencer JM
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):315-7. PubMed ID: 10025857
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
5. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
6. A comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans.
Massey RA; Tok J; Strippoli BA; Szabolcs MJ; Silvers DN; Eliezri YD
Dermatol Surg; 1998 Sep; 24(9):995-8. PubMed ID: 9754088
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma protuberans: dealing with slow Mohs procedures employing formalin-fixed, paraffin wax-embedded tissue in a busy diagnostic laboratory.
Orchard GE; Shams M
Br J Biomed Sci; 2012; 69(2):56-61. PubMed ID: 22872928
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Dermatol Surg Oncol; 1994 Oct; 20(10):687-9. PubMed ID: 7523470
[TBL] [Abstract][Full Text] [Related]
9. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature.
Sheehan DJ; Madkan V; Strickling WA; Peterson CM
Cutis; 2004 Oct; 74(4):237-42. PubMed ID: 15551716
[TBL] [Abstract][Full Text] [Related]
10. Autoamputation of Dermatofibrosarcoma Protuberans: A Novel and Rare Presentation of a Familiar Entity.
Jebastin Thangaiah J; Williamson SR; Pimentel J; Perry K
Int J Surg Pathol; 2019 Aug; 27(5):531-534. PubMed ID: 30813811
[TBL] [Abstract][Full Text] [Related]
11. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression.
Sato N; Kimura K; Tomita Y
J Dermatol; 1995 Sep; 22(9):665-72. PubMed ID: 8537553
[TBL] [Abstract][Full Text] [Related]
12. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Dermatofibrosarcoma Protuberans in a 3-Year-Old Patient.
Iyengar R; Kiwanuka E; Mangray S; Cruz AP; Katarincic J; Bhatt R
J Hand Surg Am; 2017 Sep; 42(9):756.e1-756.e5. PubMed ID: 28549894
[TBL] [Abstract][Full Text] [Related]
14. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.
Goldblum JR; Reith JD; Weiss SW
Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans: margins reduction using slow-Mohs micrographic surgery. Experience with 35 patients.
Chaput B; Filleron T; Le Guellec S; Meresse T; Courtade-Saïdi M; Grolleau JL; Chevreau C; Garrido I; Gangloff D
Ann Chir Plast Esthet; 2014 Aug; 59(4):219-25. PubMed ID: 24411817
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans with areas of giant cell fibroblastoma in the vulva: a case report.
Pascual A; Sánchez-Martínez C; Moreno C; Burdaspal-Moratilla A; López-Rodriguez MJ; Rios L
Eur J Gynaecol Oncol; 2010; 31(6):685-9. PubMed ID: 21319518
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
19. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
20. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1994 Aug; 21(4):324-9. PubMed ID: 7528229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
